Updated as of October 22, 2020 It is based on the local time of Seoul, Korea. (UTC/GMT +9:00)

• Thursday, November 12
• Friday, November 13

Date & Time	11/12(T) 09:40-10:20	Room	Room A
Viral and cellular immunotherapeutics for cancer: From research to clinical care Yuman Fong (City of Hope Medical Center, USA)

Session Title	Function preserving curable surgery for solid cancer
Date & Time	11/12(T) 15:20-17:00	Room	Room B
1) Is sphincter preservation the best way for rectal cancer? Messages from the ASPIRE study Sung-Bum Kang (Seoul National University College of Medicine)
2) Microsurgical treatment of lymphedema: Upper extremity and lower extremity Joo Hyoung Kim (Pusan National University School of Medicine)
3) Function preserving surgery for gastric cancer Ji Yeong An (Sungkyunkwan University School of Medicine)

Session Title	Young Investigator Symposium 1
Date & Time	11/12(T) 13:30-15:10	Place	Room B
1) Frontiers in theranostics Youngju Park (Seoul St. Mary’s Hospital, The Catholic University of Korea)
2) Spectroscopic tissue scanner for distinguishing between normal mucosa and submucosa, and cancer of stomach Hong Man Yoon (National Cancer Center)
3) Integrative multi-omics analysis reveals consensus molecular subtypes reflecting distinct clinical phenotypes of hepatocellular carcinoma Sung Hwan Lee (CHA University School of Medicine)
4) Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model Yoo-Young Lee (Samsung Medical Center)

Session Title	Histology-agnostic treatment approach
Date & Time	11/12(T) 10:30-12:10	Place	Room A
1) NTRK fusion-positive cancers and TRK inhibitor therapy David S. Hong (MD Anderson Cancer Center, USA)
2) Targeting the BRAF mutation Hussein A. Tawbi (MD Anderson Cancer Center, USA)
3) Analysis of TMB and MSI Status and their treatment outcomes Sae-Won Han (Seoul National University Hospital)
4) DNA damage pathways for cancer treatment Yeon Hee Park (Sungkyunkwan University School of Medicine)

Session Title	Systems biologic approach to cancer genomics
Date & Time	11/12(T) 10:30-12:10	Place	Room B
1) Oncogenic IRS4 activation in thymic epithelial tumors Young Seok Ju (Korea Advanced Institute of Science and Technology (KAIST))
2) Cross-species oncogenic signatures of breast cancer in canine mammary tumors Sangwoo Kim (Yonsei University College of Medicine)
3) Recent update of breast cancer genomics Wonshik Han (Seoul National University College of Medicine)
4) Systems biology approach to overcome the therapeutic resistance to multikinase inhibitor Jae Kyung Won (Seoul National University College of Medicine)

Session Title	Adolescents and young adults with cancer
Date & Time	11/12(T) 13:30-15:10	Place	Room A
1) The history and current status of AYA oncology Jung Woo Han (Yonsei University College of Medicine)
2) Sarcomas in adolescent and young adults (AYA) Jun Ah Lee (National Cancer Center)
3) Fertility preservation in female adolescents and young adults with cancers Jung Ryeol Lee (Seoul National University College of Medicine)
4) Survivorship of AYA with cancers Juhee Cho (Sungkyunkwan University )

Session Title	Next initiative for cancer immunotherapy
Date & Time	11/12(T) 15:20-17:00	Place	Room A
1) The power of ONE: Immunology in the age of single cell genomics Ido Amit (Weizmann Institute of Science, Israel)
2) Utilizing machine intelligence for neoantigen identification Jung Kyoon Choi (Korea Advanced Institute of Science and Technology (KAIST))
3) Machine learning-based immunogenomic analysis of TIME to predict immune directed therapy response in gastric cancer Jae-Ho Cheong (Yonsei University College of Medicine)
4) Significance of tumor-specific and non-specific T cells in cancer immunotherapy Eui-Cheol Shin (Korea Advanced Institute of Science and Technology (KAIST))

Session Title	Solidity in gastric cancer treatment: The strong value of ramucirumab for advanced gastric cancer in 2nd line
Date & Time	11/12(Thu) 08:30-08:50	Place	Room B
Hisato Kawakami (Kindai University Faculty of Medicine, Japan)

Session Title	The new era of advanced NSCLC treatment: Raising the bar for patient outcome with optimal front-line treatment
Date & Time	11/12(Thu) 08:50-09:10	Place	Room B
Se-Hoon Lee (Sungkyunkwan University School of Medicine)

Session Title	At the five-year mark: Conquering cancer and giving life back to patients
Date & Time	11/12(Thu) 09:10-09:30	Place	Room B
Se Hyun Kim (Seoul National University Bundang Hospital)

Session Title	More TOMORROWs: Pembrolizumab will double the hope for mNSCLC patients in the 1st line
Date & Time	11/12(Thu) 12:40-13:20	Place	Room A
Hye Ryun Kim (Yonsei University College of Medicine)

Date & Time	11/12(Thu) 08:30-09:30	Place	Room A
1) Spatial single-cell RNA sequencing reveals reprogramming of tumor microenvironment according to tumor invasion of diffuse-type gastric cancer Hoon Hur (Ajou University School of Medicine)
2) Molecular validation of the 8th edition AJCC cancer staging system in patients with resected pancreatic cancer: Proposal of integrative translational staging system Sung Hwan Lee (CHA University School of Medicine)
3) Investigating personalized cancer drug response at the molecular level using DRIM, a web-based integrative system Minsik Oh (Seoul National University)

Date & Time	11/13(F) 09:40-10:20	Room	Room A
Introduction	In memory of Professor Waun Ki Hong, a renowned medical oncologist, physician-scientist, and mentor, the KCA established the Waun Ki Hong Memorial Lecture to honor his dedication and seminal research legacy
Chimeric antigen receptor therapy - Clinical perspective and significance Carl H. June (University of Pennsylvania School of Medicine, USA)

Session Title	Recent update of particle radiation therapy
Date & Time	11/13(F) 15:10-16:50	Room	Room B
1) Radiation biology of particle radiation Woong Sub Koom (Yonsei University College of Medicine)
2) Radiation physics of particle radiation Haksoo Kim (National Cancer Center)
3) Recent update of proton therapy Do Hoon Lim (Sungkyunkwan University School of Medicine)
4) Recent update of carbon ion radiotherapy (CIRT) Hong-Gyun Wu (Seoul National University College of Medicine)

Session Title	Young Investigator Symposium II
Date & Time	11/13(F) 13:20-15:00	Place	Room B
1) Tumor metastasis to lymph node requires metabolic reprogramming toward fatty acid oxidation Choong-kun Lee (Yonsei University College of Medicine)
2) Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1 Jong-ho Cha (Inha University School of Medicine)
3) Immunologic response to radiotherapy in hepatocellular carcinoma Yoon Sun Choi (Inje University Busan Paik Hospital)
4) Application of artificial intelligence in colorectal cancer research Eun Kyung Choe (Seoul National University College of Medicine)

Session Title	Recent update of systemic therapy in gynecologic cancers
Date & Time	11/13(F) 10:30-12:10	Place	Room A
1) Role of Notch signaling in tumor microenvironment Kyung-Hee Chun (Yonsei University College of Medicine)
2) PARPi in epithelial ovarian cancer: Current and future Maria Lee (Seoul National University College of Medicine)
3) Preclinical drug development: Translating basic research into clinical practice Youn Jin Choi (The Catholic University of Korea College of Medicine)
4) IO drugs in gynecological cancer: Current and future Jin Young Kim (Keimyung University School of Medicine)

Session Title	Multidisciplinary translational conference (Part 1 & 2)
Date & Time	11/13(F) 10:30-12:10	Place	Room B
1) Development of an NGS-based prognostic tool with clinical utility Han-Byoel Lee (Seoul National University College of Medicine)
2) Algorithm modelling using gene expression data Sungroh Yoon (Seoul National University College of Engineering)
3) Multi-omics data analysis to solve clinical unmet needs of advanced cancer Se-Hoon Lee (Sungkyunkwan University School of Medicine) Semin Lee (Ulsan National Institute of Science and Technology)

Session Title	Resistance mechanisms and new target discovery
Date & Time	11/13(F) 13:20-15:00	Place	Room A
1) Resistance to immune checkpoint inhibitors: Next steps for new approaches Michele Woei Ling Teng (QIMR Berghofer Medical Research Institute, Australia)
2) Overcoming EGFR TKIs resistance to EGFR mutant NSCLC James Chih-Hsin Yang (National Taiwan University Cancer Center, Taiwan)
3) Strategies to overcome trastuzumab resistance in HER2 overexpressing breast cancers: Focus on new data from clinical trials Jee Hyun Kim (Seoul National University College of Medicine)
4) Understanding and overcoming the mechanisms of castration-resistance in prostate cancer Inkeun Park (Gachon University College of Medicine)

Session Title	난치성 암환자의 치료를 위한 제도와 급여정책
Date & Time	11/13(F) 15:10-16:50	Place	Room A
1) 난치성 암환자의 치료를 위한 제도와 급여정책 (임상가 측면) 김열홍 (고려의대)
2) 난치성 암환자의 치료를 위한 제도 안미령 (식품의약품안전평가원)
3) 난치성 암환자의 치료를 위한 급여정책 하성희 (건강보험심사평가원)
4) 암관련 보건의료 빅데이터 및 real-world data 활용 - 대한간암학회-중앙암등록본부 간암등록사업의 사례를 중심으로 이정훈 (서울의대)
5) Panel Discussion

Session Title	Expanded benefit for 1L ES-SCLC patients with Tecentriq combination therapy
Date & Time	11/13(Fri) 12:40-13:10	Place	Room A
Min Hee Hong (Yonsei University College of Medicine)

Session Title	Liposomal irinotecan in metastatic pancreatic cancer: Asian and Korean experiences
Date & Time	11/13(Fri) 12:40-13:10	Place	Room B
Changhoon Yoo (University of Ulsan College of Medicine)

Date & Time	11/13(Fri) 08:30-09:30	Place	Room A
1) Engineering and characterization of oncolytic vaccinia virus expressing truncated herpes simplex virus thymidine kinase S M BAKHTIAR UL ISLAM (Pusan National University)
2) A proteomic landscape of precancerous gastric lesions and gastric cancer in high-risk population Xue Li (Peking University Cancer Hospital & Institute, China)
3) Automated detection improves identification of oligometastatic disease and prevention of missing metastases during metastasis-directed therapy Jason Joon Bock Lee (Yonsei University College of Medicine)
4) Single patient classifier as a prognostic biomarker for pT1N1 gastric cancer: Results from two large cohorts in Korea Yoon Young Choi (CHA University College of Medicine)
5) Functional bypass of cell cycle entry checkpoints by MYC T58A mutation in germinal center-derived lymphomas Jongkuen Lee (Icahn School of Medicine at Mount Sinai, USA)
6) Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01) Chan Woo Wee (SMG-SNU Boramae Medical Center)

Date & Time	11/13(Fri) 08:30-09:30	Place	Room B
1) Development of the prediction model based on radiation response and mutational profile revealed from targeted gene-sequencing using FIRST cancer panel Bum-Sup Jang (Seoul National University Bundang Hospital)
2) Clinical usage for rare cancer(NUT carcinoma) diagnosis and guidance of potential targeted therapies Sungbin An (Sungkyunkwan University)
3) Dacomitinib vs gefitinib in first-line treatment of advanced epidermal growth factor receptor-activating mutation-positive (EGFR+) non-small cell lung cancer (NSCLC) (ARCHER 1050): Korean subset Dong-Wan Kim (Seoul National University College of Medicine)
4) Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux Chul-Ho Kim (Ajou University School of Medicine)
5) Lung cancer exosome specific protein 1 (LESP-1) as a potential biomarker for early diagnosis and therapeutic target for non-small cell lung cancer Byeong Hyeon Choi (Korea University College of Medicine)
6) Cigarette smoking is associated with increased risk of malignant gliomas: A nationwide population-based cohort study Seung Ho Yang (The Catholic University of Korea College of Medicine)